[144] The Buckle, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for The Buckle, Inc. (BKE) reports a proposed sale of 20,000 common shares through UBS Financial Services with an aggregate market value of $1,120,000, representing part of the company's 51,160,000 shares outstanding. The planned approximate sale date is 08/25/2025 on the NYSE. The securities to be sold were acquired as restricted stock units (RSUs) granted by the issuer on multiple dates: 01/29/2022 (4,700 shares), 03/21/2022 (1,600), 02/03/2024 (11,300) and 03/25/2024 (2,400). No shares were reported sold in the past three months. The filer certifies they are not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider plans to sell RSU-derived shares worth ~$1.12M on 08/25/2025; transaction appears routine and non-material to outstanding float.

The filing is a standard Form 144 notice indicating an insider will execute a sale through UBS. The shares were obtained as compensation (RSUs) over 2022 and 2024. Relative to the 51.16M shares outstanding, 20,000 shares equal roughly 0.04% of the outstanding common stock, so this notice alone is unlikely to be material to valuation or control. No recent sales in the prior three months are reported, which limits immediate trend inference.

Corporate Governance Expert

TL;DR: This is a routine disclosure of an intended sale of vested RSUs; it raises standard governance transparency but no red flags.

The filer discloses the nature and dates of RSU grants and confirms the absence of undisclosed material information. The use of a broker and the formal Form 144 filing align with compliance expectations for insider dispositions. There are no indications of clustered insider selling or other governance concerns within this document alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	20000	1120000	51160000	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	03/25/2024	Compensation (RSUs)	Issuer			2400	03/25/2024	Compensation (RSUs)
common	02/03/2024	Compensation (RSUs)	issuer			11300	02/03/2024	Compensation (RSUs)
common	03/21/2022	Compensation (RSUs)	issuer			1600	03/21/2022	Compensation (RSUs)
common	01/29/2022	Compensation (RSUs)	issuer			4700	01/29/2022	Compensation (RSUs)

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for The Buckle, Inc. (BKE) disclose?

The filing discloses a proposed sale of 20,000 common shares via UBS with an aggregate market value of $1,120,000, planned for 08/25/2025 on the NYSE.

How were the shares being sold acquired?

All reported shares were acquired as compensation (RSUs) on dates: 01/29/2022 (4,700), 03/21/2022 (1,600), 02/03/2024 (11,300) and 03/25/2024 (2,400).

Does the filing report any sales in the past three months by the filer?

No. The filing states Nothing to Report for securities sold during the past three months.

What portion of outstanding shares does the proposed sale represent?

The filing lists 51,160,000 shares outstanding; 20,000 shares represent approximately 0.04% of that total.

Did the filer make any certification about material information?

Yes. By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.